stockrowBurning Rock Biotech Limited Sponsored ADR (BNR) vs Myriad Genetics, Inc. (MYGN)
- Burning Rock Biotech Limited Sponsored ADR BNR 13.42 +1.28%
- Myriad Genetics, Inc. MYGN 6.07 −3.50%
Burning Rock Biotech Limited Sponsored ADR and Myriad Genetics, Inc. are both Diagnostics & Research companies. Myriad Genetics, Inc. is the larger, with a market value of $601.6M against $116.5M — 5.2× the size. Burning Rock Biotech Limited Sponsored ADR grew revenue faster over the last twelve months: −0.14% against −3.16%. Burning Rock Biotech Limited Sponsored ADR has the higher net margin (−13.5% vs −14.0%) and the lower return on invested capital (−50.7% vs −19.9%). Across the 18 metrics below, Burning Rock Biotech Limited Sponsored ADR leads on 10 and Myriad Genetics, Inc. on 8.
Valuation
Profitability
| Metric | BNR | MYGN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 74.50% | 68.83% | 48.32% |
| Operating margin | (12.95%) | (12.22%) | (5.68%) |
| Net margin | (13.51%) | (13.96%) | (4.10%) |
| Free cash flow margin | (3.00%) | (1.76%) | 0.00% |
| Return on equity | (13.08%) | (32.54%) | 0.00% |
| Return on assets | (8.81%) | (17.11%) | (6.05%) |
| Return on invested capital | (50.66%) | (19.92%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack